monday.com Ltd. (MNDY) Spending and interest coverage
- R&D / revenue · 12 months: Value 26.04%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value 14.37%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 26.04% | Research and development expense / revenue. Period ending 2025-12-31. $320.80M ÷ $1.23B × 100 ≈ 26.04% |
| Stock-based compensation / revenue · 12 months | 14.37% | Share-based compensation / revenue. Period ending 2025-12-31. $177.01M ÷ $1.23B × 100 ≈ 14.37% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 320.80M USD | Research and Development Expense |
| Revenue | 1.23B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 177.01M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -1.75M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $320.80M | $1.23B | $177.01M | $-1.75M | (m) | 26.04% | 14.37% | (m) | (m) |
| 2025-06-30 | $275.26M | $1.05B | $153.65M | $-19.56M | (m) | 26.09% | 14.57% | (m) | (m) |
| 2024-12-31 | $213.71M | $972.00M | $129.21M | $-21.03M | (m) | 21.99% | 13.29% | (m) | (m) |
| 2024-06-30 | $175.20M | $764.96M | $112.11M | $-6.89M | (m) | 22.90% | 14.66% | (m) | (m) |
| 2023-12-31 | $156.50M | $729.70M | $100.19M | $-38.59M | (m) | 21.45% | 13.73% | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $127.05M | $519.03M | $104.92M | $-152.01M | (m) | 24.48% | 20.21% | (m) | (m) |
| 2021-12-31 | $73.69M | $308.15M | $73.53M | $-126.13M | (m) | 23.91% | 23.86% | (m) | (m) |
| 2020-12-31 | $43.48M | $161.12M | $64.34M | $-150.54M | (m) | 26.99% | 39.94% | (m) | (m) |
| 2019-12-31 | $24.64M | $78.09M | $21.84M | $-92.52M | (m) | 31.55% | 27.97% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.